Does Sodium Chloride Sodium Gluconate Sodium Acetate Potassium Ch Interact with Angiotensin Ii?
CDI records a major classification for Sodium Chloride Sodium Gluconate Sodium Acetate Potassium Ch and Angiotensin Ii. The stored summary is: Angiotensin II receptor antagonists increase hyperkalemia risk; avoid use due to potassium content or monitor serum potassium concentrations. The mechanism involves increased potassium risk. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Angiotensin Ii Class
- Vasoconstrictor
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
increased potassium risk
What To Tell Your Doctor or Pharmacist
If you are taking Sodium Chloride Sodium Gluconate Sodium Acetate Potassium Ch and your doctor is considering prescribing Angiotensin Ii (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider